{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T11:35:05Z","timestamp":1769859305398,"version":"3.49.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T00:00:00Z","timestamp":1675382400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,2,3]]},"abstract":"<jats:p>Epidemiological studies have shown that people having hyperuricemia are at increased risk of ischemic cerebrovascular disease. This research aimed to study the relation of ischemic cerebrovascular disease with benzbromarone use among persons with gout-related disorders. This was a retrospective cohort design utilizing a 2003 to 2015 national health insurance database in Taiwan. Subjects aged 20 to 99 years who already had suffered from gout-related disorders were included as eligible subjects. Eligible persons who had the benzbromarone prescription alone were selected into the benzbromarone group. Sex-matched and age-matched eligible persons who never used any urate-lowering agents were selected into the control group. An index date was set as a date of benzbromarone being prescribed. The end-point was defined as ischemic cerebrovascular disease being newly diagnosed. A hazard ratio was applied to measure the association strength between benzbromarone use and ischemic cerebrovascular disease. Totally, there were 13,398 persons in the benzbromarone group and 13,398 persons in the control group. The incidence rate of ischemic cerebrovascular disease seemed to be modestly higher in the benzbromarone group than the control group, but it did not achieve statistical significance (0.78 vs 0.75 every 100 person-years, incidence rate ratio = 1.05, 95% confidence interval = 0.94\u20131.16). A crude hazard ratio of ischemic cerebrovascular disease showed 1.05 in the benzbromarone group (95% confidence interval = 0.94\u20131.17, <jats:italic toggle=\"yes\">P<\/jats:italic> = .373) comparing with the control group. No significant association can be detected between benzbromarone use and the probability of ischemic cerebrovascular disease among persons with gout-related disorders. We think that reduction of the serum uric acid by use of benzbromarone could not be related to the probability of ischemic cerebrovascular disease. Further research is suggested to clarify this issue.<\/jats:p>","DOI":"10.1097\/md.0000000000032779","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T15:10:45Z","timestamp":1675782645000},"page":"e32779","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["The risk of ischemic cerebrovascular disease associated with benzbromarone use in gout people: A retrospective cohort study in Taiwan"],"prefix":"10.1097","volume":"102","author":[{"given":"Shih-Wei","family":"Lai","sequence":"first","affiliation":[{"name":"Department of Public Health, College of Public Health, and School of Medicine, College of Medicine, China Medical University, Taichung, TaiwanDepartment of Family Medicine, China Medical University Hospital, Taichung, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuan-Fu","family":"Liao","sequence":"additional","affiliation":[{"name":"College of Medicine, Tzu Chi University, Hualien, Taiwan, Division of Hepatogastroenterology, Department of Internal Medicine, Taichung Tzu Chi Hospital, Taichung, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Hung","family":"Kuo","sequence":"additional","affiliation":[{"name":"Department of Research, Taichung Tzu Chi Hospital, Taichung, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing-Fang","family":"Hwang","sequence":"additional","affiliation":[{"name":"Department of Occupational Safety and Health, College of Public Health, China Medical University, Taichung, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiu-Shong","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, China Medical University Hospital, Taichung, Taiwan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1056\/NEJMcp1001124","article-title":"Clinical practice. Gout.","volume":"364","author":"Neogi","year":"2011","journal-title":"N Engl J Med"},{"key":"R2-20250504","first-page":"831","article-title":"Diagnosis, treatment, and prevention of gout.","volume":"90","author":"Hainer","year":"2014","journal-title":"Am Fam Physician"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1093\/rheumatology\/kez196","article-title":"Gout and hyperuricaemia in the USA: prevalence and trends.","volume":"58","author":"Singh","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"R4-20250504","first-page":"301","article-title":"Trends in hyperuricemia and gout prevalence: Nutrition and Health Survey in Taiwan from 1993-1996 to 2005-2008.","volume":"20","author":"Chuang","year":"2011","journal-title":"Asia Pac J Clin Nutr"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.rdc.2019.08.001","article-title":"Gout.","volume":"45","author":"Perez-Ruiz","year":"2019","journal-title":"Rheum Dis Clin North Am"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s40292-014-0046-3","article-title":"Hyperuricemia and cardiovascular risk.","volume":"21","author":"Grassi","year":"2014","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/art.24612","article-title":"Hyperuricemia and risk of stroke: a systematic review and meta-analysis.","volume":"61","author":"Kim","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R8-20250504","first-page":"66","article-title":"Serum uric acid levels and serum lipid levels in patients with ischemic cerebrovascular accident.","volume":"66","author":"Arora","year":"2018","journal-title":"J Assoc Physicians India"},{"key":"R9-20250504","first-page":"66","article-title":"Serum uric acid level in acute stroke patients.","volume":"26","author":"Mehrpour","year":"2012","journal-title":"Med J Islam Repub Iran"},{"key":"R10-20250504","first-page":"e10899","article-title":"Association between hyperuricemia and acute ischemic stroke in patients at a tertiary care hospital.","volume":"12","author":"Irfan","year":"2020","journal-title":"Cureus"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"e0236747","DOI":"10.1371\/journal.pone.0236747","article-title":"Role of serum uric acid in ischemic stroke: a case-control study in Bangladesh.","volume":"15","author":"Khalil","year":"2020","journal-title":"PLoS One"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1161\/01.STR.0000221716.55088.d4","article-title":"Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study.","volume":"37","author":"Bos","year":"2006","journal-title":"Stroke"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.atherosclerosis.2005.09.020","article-title":"Serum uric acid and risk of ischemic stroke: the ARIC Study.","volume":"187","author":"Hozawa","year":"2006","journal-title":"Atherosclerosis"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2165\/00002018-200831080-00002","article-title":"A benefit-risk assessment of benzbromarone in the treatment of gout. Was its withdrawal from the market in the best interest of patients?","volume":"31","author":"Lee","year":"2008","journal-title":"Drug Saf"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/pds.2087","article-title":"Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan.","volume":"20","author":"Cheng","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1159\/000324847","article-title":"Serum uric acid level and endothelial dysfunction in patients with nondiabetic chronic kidney disease.","volume":"33","author":"Kanbay","year":"2011","journal-title":"Am J Nephrol"},{"key":"R17-20250504","first-page":"810","article-title":"Uric acid as a predictor of endothelial dysfunction in patients with metabolic syndrome.","volume":"64","author":"Singh","year":"2021","journal-title":"Arch Endocrinol Metab"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fmed.2018.00160","article-title":"Physiology of hyperuricemia and urate-lowering treatments.","volume":"5","author":"Benn","year":"2018","journal-title":"Front Med"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.atherosclerosis.2018.10.007","article-title":"Hyperuricemia and endothelial function: From molecular background to clinical perspectives.","volume":"278","author":"Maruhashi","year":"2018","journal-title":"Atherosclerosis"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2017.05.005","article-title":"Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases.","volume":"100","author":"Incalza","year":"2018","journal-title":"Vascul Pharmacol"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00059-013-3759-5","article-title":"Endothelial dysfunction is an independent risk factor for stroke patients irrespective of the presence of patent foramen ovale.","volume":"38","author":"Sunbul","year":"2013","journal-title":"Herz"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"e015703","DOI":"10.1161\/JAHA.119.015703","article-title":"Incremental prognostic impact of peripheral microvascular endothelial dysfunction on the development of ischemic stroke.","volume":"9","author":"Toya","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1159\/000212672","article-title":"Endothelial dysfunction in lacunar stroke: a systematic review.","volume":"27","author":"Knottnerus","year":"2009","journal-title":"Cerebrovasc Dis"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s42358-019-0080-x","article-title":"Benzbromarone in the treatment of gout.","volume":"59","author":"Azevedo","year":"2019","journal-title":"Adv Rheumatol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"e8366","DOI":"10.1097\/MD.0000000000008366","article-title":"Head and neck cancer associated with increased rate of pulmonary tuberculosis in a population-based cohort study.","volume":"96","author":"Lai","year":"2017","journal-title":"Medicine (Baltim)"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"351","DOI":"10.5144\/0256-4947.2017.351","article-title":"Risk of pneumonia among patients with splenectomy: a retrospective population-based cohort study.","volume":"37","author":"Lai","year":"2017","journal-title":"Ann Saudi Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000032779","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:44:23Z","timestamp":1746326663000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000032779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,3]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000032779","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,3]]}}}